ZA200405982B - Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group. - Google Patents
Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group. Download PDFInfo
- Publication number
- ZA200405982B ZA200405982B ZA200405982A ZA200405982A ZA200405982B ZA 200405982 B ZA200405982 B ZA 200405982B ZA 200405982 A ZA200405982 A ZA 200405982A ZA 200405982 A ZA200405982 A ZA 200405982A ZA 200405982 B ZA200405982 B ZA 200405982B
- Authority
- ZA
- South Africa
- Prior art keywords
- phenyl
- pyrrolo
- dimethyl
- piperidin
- salkyl
- Prior art date
Links
- 125000003277 amino group Chemical group 0.000 title claims description 96
- 125000004122 cyclic group Chemical group 0.000 title claims description 96
- XWIYUCRMWCHYJR-UHFFFAOYSA-N 1h-pyrrolo[3,2-b]pyridine Chemical group C1=CC=C2NC=CC2=N1 XWIYUCRMWCHYJR-UHFFFAOYSA-N 0.000 title claims description 30
- KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical group C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 title claims description 11
- -1 saturated cyclic amine Chemical class 0.000 claims description 206
- 229910052739 hydrogen Inorganic materials 0.000 claims description 161
- 239000001257 hydrogen Substances 0.000 claims description 161
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 91
- 150000002431 hydrogen Chemical class 0.000 claims description 56
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 48
- 125000001424 substituent group Chemical group 0.000 claims description 46
- 150000003839 salts Chemical class 0.000 claims description 44
- 150000004677 hydrates Chemical class 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 42
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims description 42
- 229910052736 halogen Inorganic materials 0.000 claims description 40
- 150000002367 halogens Chemical class 0.000 claims description 40
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 34
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 34
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 31
- 125000003118 aryl group Chemical group 0.000 claims description 30
- 125000004432 carbon atom Chemical group C* 0.000 claims description 29
- 125000001072 heteroaryl group Chemical group 0.000 claims description 27
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 25
- 125000004076 pyridyl group Chemical group 0.000 claims description 23
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 22
- 150000004944 pyrrolopyrimidines Chemical group 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 108010056643 Corticotropin-Releasing Hormone Receptors Proteins 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000005557 antagonist Substances 0.000 claims description 4
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 3
- 150000001204 N-oxides Chemical class 0.000 claims description 2
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 54
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 50
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 26
- 125000001246 bromo group Chemical group Br* 0.000 claims 10
- 125000001309 chloro group Chemical group Cl* 0.000 claims 10
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 10
- 150000002148 esters Chemical class 0.000 claims 3
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 3
- FSDNTQSJGHSJBG-UHFFFAOYSA-N piperidine-4-carbonitrile Chemical compound N#CC1CCNCC1 FSDNTQSJGHSJBG-UHFFFAOYSA-N 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- RMIODHQZRUFFFF-UHFFFAOYSA-N methoxyacetic acid Chemical compound COCC(O)=O RMIODHQZRUFFFF-UHFFFAOYSA-N 0.000 claims 2
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 claims 2
- MGVNSMKDNCTMGY-UHFFFAOYSA-N 1-[1-(2,4-dibromophenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC3)C#N)=C2C(C)=CN1C1=CC=C(Br)C=C1Br MGVNSMKDNCTMGY-UHFFFAOYSA-N 0.000 claims 1
- HDLXAJBKOSQRAS-UHFFFAOYSA-N 1-[1-(2,4-dichlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-3-carbonitrile Chemical compound CC1=C(C)C2=C(N3CC(CCC3)C#N)C=C(C)N=C2N1C1=CC=C(Cl)C=C1Cl HDLXAJBKOSQRAS-UHFFFAOYSA-N 0.000 claims 1
- LTLJVEBSOOFJMA-UHFFFAOYSA-N 1-[1-(2,4-dichlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC3)C#N)C=C(C)N=C2N1C1=CC=C(Cl)C=C1Cl LTLJVEBSOOFJMA-UHFFFAOYSA-N 0.000 claims 1
- LKZAEXTVJAYNMD-UHFFFAOYSA-N 1-[1-(2,6-dibromo-4-chlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC3)C#N)C=C(C)N=C2N1C1=C(Br)C=C(Cl)C=C1Br LKZAEXTVJAYNMD-UHFFFAOYSA-N 0.000 claims 1
- MIXVUYODFGYIIS-UHFFFAOYSA-N 1-[1-(2,6-dibromo-4-propan-2-ylphenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound BrC1=CC(C(C)C)=CC(Br)=C1N1C2=NC(C)=CC(N3CCC(CC3)C#N)=C2C(C)=C1C MIXVUYODFGYIIS-UHFFFAOYSA-N 0.000 claims 1
- CFIJLSZQATYTHY-UHFFFAOYSA-N 1-[1-(4-bromo-2,6-dimethylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-3-carbonitrile Chemical compound C12=NC(C)=CC(N3CC(CCC3)C#N)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C CFIJLSZQATYTHY-UHFFFAOYSA-N 0.000 claims 1
- AQLJEXFJKCOLFF-UHFFFAOYSA-N 1-[1-(4-chloro-2,6-dimethylphenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC3)C#N)C=C(C)N=C2N1C1=C(C)C=C(Cl)C=C1C AQLJEXFJKCOLFF-UHFFFAOYSA-N 0.000 claims 1
- XKEJIPYRXPSDSZ-UHFFFAOYSA-N 1-[1-(4-chloro-2,6-dimethylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC3)C#N)=C2C(C)=CN1C1=C(C)C=C(Cl)C=C1C XKEJIPYRXPSDSZ-UHFFFAOYSA-N 0.000 claims 1
- HXBOZUOTSHPQGM-UHFFFAOYSA-N 1-[1-[1-(4-bromo-2,6-dimethylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethane-1,2-diol Chemical compound C12=NC(C)=CC(N3CCC(CC3)C(O)CO)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C HXBOZUOTSHPQGM-UHFFFAOYSA-N 0.000 claims 1
- GWWYMRBDNHGASK-UHFFFAOYSA-N 1-[1-[2-bromo-4-(trifluoromethyl)phenyl]-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC3)C#N)=C2C(C)=CN1C1=CC=C(C(F)(F)F)C=C1Br GWWYMRBDNHGASK-UHFFFAOYSA-N 0.000 claims 1
- UBQCWWKXQTWSKR-UHFFFAOYSA-N 1-[1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]ethanol Chemical compound C1CC(C(O)C)CCN1C1=NC(C)=NC2=C1C(C)=C(C)N2C1=C(C)C=C(Br)C=C1C UBQCWWKXQTWSKR-UHFFFAOYSA-N 0.000 claims 1
- VRSVQZKQWJBBMK-UHFFFAOYSA-N 1-[1-[7-(4-chloro-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]ethanol Chemical compound C1CC(C(O)C)CCN1C1=NC(C)=NC2=C1C(C)=C(C)N2C1=C(C)C=C(Cl)C=C1C VRSVQZKQWJBBMK-UHFFFAOYSA-N 0.000 claims 1
- ASDIAGHLEYKJHH-UHFFFAOYSA-N 1-[2,3,6-trimethyl-1-(2,4,5-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC3)C#N)C=C(C)N=C2N1C1=CC(Br)=C(Br)C=C1Br ASDIAGHLEYKJHH-UHFFFAOYSA-N 0.000 claims 1
- QDSSCAURYMAEFJ-UHFFFAOYSA-N 1-[2,3,6-trimethyl-1-(2,4,6-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC3)C#N)C=C(C)N=C2N1C1=C(Br)C=C(Br)C=C1Br QDSSCAURYMAEFJ-UHFFFAOYSA-N 0.000 claims 1
- DLUUYIAQWRKXHP-UHFFFAOYSA-N 1-[3,6-dimethyl-1-(2,4,5-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC3)C#N)=C2C(C)=CN1C1=CC(Br)=C(Br)C=C1Br DLUUYIAQWRKXHP-UHFFFAOYSA-N 0.000 claims 1
- BVPGDIGXFRHSOC-UHFFFAOYSA-N 1-[3,6-dimethyl-1-(2,4,6-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidine-4-carbonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC3)C#N)=C2C(C)=CN1C1=C(Br)C=C(Br)C=C1Br BVPGDIGXFRHSOC-UHFFFAOYSA-N 0.000 claims 1
- HKHJQXCPYCGKAD-UHFFFAOYSA-N 1-[7-(4-bromo-2,6-diethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidine-3-carbonitrile Chemical compound CCC1=CC(Br)=CC(CC)=C1N1C2=NC(C)=NC(N3CC(CCC3)C#N)=C2C(C)=C1 HKHJQXCPYCGKAD-UHFFFAOYSA-N 0.000 claims 1
- QTEKZKBLFLXAON-UHFFFAOYSA-N 1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidine-3-carbonitrile Chemical compound CC1=C(C)C2=C(N3CC(CCC3)C#N)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C QTEKZKBLFLXAON-UHFFFAOYSA-N 0.000 claims 1
- VMLFTDFVFBRLTL-UHFFFAOYSA-N 1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]pyrrolidine-3-carbonitrile Chemical compound CC1=C(C)C2=C(N3CC(CC3)C#N)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C VMLFTDFVFBRLTL-UHFFFAOYSA-N 0.000 claims 1
- IBFBWKGXWGVBJA-UHFFFAOYSA-N 1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]azepane-4-carbonitrile Chemical compound C12=NC(C)=NC(N3CCC(CCC3)C#N)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C IBFBWKGXWGVBJA-UHFFFAOYSA-N 0.000 claims 1
- TWAJCMRSSAYRLO-UHFFFAOYSA-N 1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidine-4-carbonitrile Chemical compound C12=NC(C)=NC(N3CCC(CC3)C#N)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C TWAJCMRSSAYRLO-UHFFFAOYSA-N 0.000 claims 1
- XKUVKDVHDROZBE-UHFFFAOYSA-N 1-[7-[2,6-dibromo-4-(trifluoromethyl)phenyl]-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidine-3-carbonitrile Chemical compound CC1=C(C)C2=C(N3CC(CCC3)C#N)N=C(C)N=C2N1C1=C(Br)C=C(C(F)(F)F)C=C1Br XKUVKDVHDROZBE-UHFFFAOYSA-N 0.000 claims 1
- WYAMKPADTZURPG-UHFFFAOYSA-N 2-[1-[1-(2,4-dibromophenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=CC=C(Br)C=C1Br WYAMKPADTZURPG-UHFFFAOYSA-N 0.000 claims 1
- ZMBRIOFYOCHDHE-UHFFFAOYSA-N 2-[1-[1-(2,4-dichlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-3-yl]ethanol Chemical compound CC1=C(C)C2=C(N3CC(CCO)CCC3)C=C(C)N=C2N1C1=CC=C(Cl)C=C1Cl ZMBRIOFYOCHDHE-UHFFFAOYSA-N 0.000 claims 1
- QXNYABHUACQZBI-UHFFFAOYSA-N 2-[1-[1-(2,4-dichlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC#N)CC3)C=C(C)N=C2N1C1=CC=C(Cl)C=C1Cl QXNYABHUACQZBI-UHFFFAOYSA-N 0.000 claims 1
- SCFCLXHRLULCGM-UHFFFAOYSA-N 2-[1-[1-(2,6-dibromo-4-chlorophenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound C12=NC(C)=CC(N3CCC(CCO)CC3)=C2C(C)=CN1C1=C(Br)C=C(Cl)C=C1Br SCFCLXHRLULCGM-UHFFFAOYSA-N 0.000 claims 1
- QYFGOSXQSPHJLD-UHFFFAOYSA-N 2-[1-[1-(2,6-dibromo-4-propan-2-ylphenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound BrC1=CC(C(C)C)=CC(Br)=C1N1C2=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=C1C QYFGOSXQSPHJLD-UHFFFAOYSA-N 0.000 claims 1
- HSIPWAIJVKVXIB-UHFFFAOYSA-N 2-[1-[1-(2,6-dibromo-4-propan-2-ylphenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound BrC1=CC(C(C)C)=CC(Br)=C1N1C2=NC(C)=CC(N3CCC(CCO)CC3)=C2C(C)=C1C HSIPWAIJVKVXIB-UHFFFAOYSA-N 0.000 claims 1
- SDZNYWPOJYYOBN-UHFFFAOYSA-N 2-[1-[1-(2,6-dibromo-4-propan-2-ylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound BrC1=CC(C(C)C)=CC(Br)=C1N1C2=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=C1 SDZNYWPOJYYOBN-UHFFFAOYSA-N 0.000 claims 1
- ZORBZVDVNRTURS-UHFFFAOYSA-N 2-[1-[1-(2,6-dibromo-4-propan-2-ylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound BrC1=CC(C(C)C)=CC(Br)=C1N1C2=NC(C)=CC(N3CCC(CCO)CC3)=C2C(C)=C1 ZORBZVDVNRTURS-UHFFFAOYSA-N 0.000 claims 1
- YFWVVTZMAJWQCF-UHFFFAOYSA-N 2-[1-[1-(2-bromo-4-propan-2-ylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound BrC1=CC(C(C)C)=CC=C1N1C2=NC(C)=CC(N3CCC(CCO)CC3)=C2C(C)=C1 YFWVVTZMAJWQCF-UHFFFAOYSA-N 0.000 claims 1
- GBMWKBFGKAFXAO-UHFFFAOYSA-N 2-[1-[1-(4-bromo-2,6-dichlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound CC1=C(C)C2=C(N3CCC(CCO)CC3)C=C(C)N=C2N1C1=C(Cl)C=C(Br)C=C1Cl GBMWKBFGKAFXAO-UHFFFAOYSA-N 0.000 claims 1
- RMDXFCFGULPTPV-UHFFFAOYSA-N 2-[1-[1-(4-bromo-2,6-dichlorophenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=C(Cl)C=C(Br)C=C1Cl RMDXFCFGULPTPV-UHFFFAOYSA-N 0.000 claims 1
- KTBHZFJQSJNLKJ-UHFFFAOYSA-N 2-[1-[1-(4-bromo-2,6-dichlorophenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound C12=NC(C)=CC(N3CCC(CCO)CC3)=C2C(C)=CN1C1=C(Cl)C=C(Br)C=C1Cl KTBHZFJQSJNLKJ-UHFFFAOYSA-N 0.000 claims 1
- JCAYVXVGQSUSOX-UHFFFAOYSA-N 2-[1-[1-(4-bromo-2,6-dimethylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C JCAYVXVGQSUSOX-UHFFFAOYSA-N 0.000 claims 1
- XBCWTGJYPAZRSC-UHFFFAOYSA-N 2-[1-[1-(4-bromo-2,6-dimethylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound C12=NC(C)=CC(N3CCC(CCO)CC3)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C XBCWTGJYPAZRSC-UHFFFAOYSA-N 0.000 claims 1
- ATUNWBVIJXIRQT-UHFFFAOYSA-N 2-[1-[1-(4-methoxy-2,6-dimethylphenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CC1=CC(OC)=CC(C)=C1N1C2=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=C1C ATUNWBVIJXIRQT-UHFFFAOYSA-N 0.000 claims 1
- DLTSRPJDTXDDNX-UHFFFAOYSA-N 2-[1-[1-(4-methoxy-2,6-dimethylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CC1=CC(OC)=CC(C)=C1N1C2=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=C1 DLTSRPJDTXDDNX-UHFFFAOYSA-N 0.000 claims 1
- USNPZJXBJGHNMP-UHFFFAOYSA-N 2-[1-[2,3,6-trimethyl-1-(2,4,6-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound CC1=C(C)C2=C(N3CCC(CCO)CC3)C=C(C)N=C2N1C1=C(Br)C=C(Br)C=C1Br USNPZJXBJGHNMP-UHFFFAOYSA-N 0.000 claims 1
- DDDIQFPNSQUDMN-UHFFFAOYSA-N 2-[1-[2,3,6-trimethyl-1-(2,4,6-trichlorophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC#N)CC3)C=C(C)N=C2N1C1=C(Cl)C=C(Cl)C=C1Cl DDDIQFPNSQUDMN-UHFFFAOYSA-N 0.000 claims 1
- IRLMOEJUDHQVJP-UHFFFAOYSA-N 2-[1-[2,3,6-trimethyl-1-(2,4,6-trichlorophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound CC1=C(C)C2=C(N3CCC(CCO)CC3)C=C(C)N=C2N1C1=C(Cl)C=C(Cl)C=C1Cl IRLMOEJUDHQVJP-UHFFFAOYSA-N 0.000 claims 1
- VLRSDFNGLBXMNU-UHFFFAOYSA-N 2-[1-[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC#N)CC3)N=C(C)N=C2N1C1=C(C)C=C(C)C=C1C VLRSDFNGLBXMNU-UHFFFAOYSA-N 0.000 claims 1
- KIASWYODDFKBKU-UHFFFAOYSA-N 2-[1-[2,5-dimethyl-7-(2,4,6-tribromophenyl)pyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=NC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=C(Br)C=C(Br)C=C1Br KIASWYODDFKBKU-UHFFFAOYSA-N 0.000 claims 1
- DYRGXKZGTREIEX-UHFFFAOYSA-N 2-[1-[3,6-dimethyl-1-(2,4,5-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=CC(Br)=C(Br)C=C1Br DYRGXKZGTREIEX-UHFFFAOYSA-N 0.000 claims 1
- HCRNVYMYTHDKLA-UHFFFAOYSA-N 2-[1-[3,6-dimethyl-1-(2,4,5-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound C12=NC(C)=CC(N3CCC(CCO)CC3)=C2C(C)=CN1C1=CC(Br)=C(Br)C=C1Br HCRNVYMYTHDKLA-UHFFFAOYSA-N 0.000 claims 1
- RKLAXKYZDSYOTK-UHFFFAOYSA-N 2-[1-[3,6-dimethyl-1-(2,4,6-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=C(Br)C=C(Br)C=C1Br RKLAXKYZDSYOTK-UHFFFAOYSA-N 0.000 claims 1
- ILJJYOWGUOTENT-UHFFFAOYSA-N 2-[1-[3,6-dimethyl-1-(2,4,6-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]ethanol Chemical compound C12=NC(C)=CC(N3CCC(CCO)CC3)=C2C(C)=CN1C1=C(Br)C=C(Br)C=C1Br ILJJYOWGUOTENT-UHFFFAOYSA-N 0.000 claims 1
- YRXQCEGOYUTJPF-UHFFFAOYSA-N 2-[1-[3,6-dimethyl-1-(2-methylsulfanyl-4-propan-2-ylphenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CSC1=CC(C(C)C)=CC=C1N1C2=NC(C)=CC(N3CCC(CC#N)CC3)=C2C(C)=C1 YRXQCEGOYUTJPF-UHFFFAOYSA-N 0.000 claims 1
- VBBKNJZVABVJHD-UHFFFAOYSA-N 2-[1-[7-(2,6-dibromo-4-chlorophenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=NC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=C(Br)C=C(Cl)C=C1Br VBBKNJZVABVJHD-UHFFFAOYSA-N 0.000 claims 1
- VWKCUHRJYRYAST-UHFFFAOYSA-N 2-[1-[7-(2,6-dibromo-4-propan-2-ylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound BrC1=CC(C(C)C)=CC(Br)=C1N1C2=NC(C)=NC(N3CCC(CC#N)CC3)=C2C(C)=C1 VWKCUHRJYRYAST-UHFFFAOYSA-N 0.000 claims 1
- BPPFPTRSIAYSTC-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-diethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CCC1=CC(Br)=CC(CC)=C1N1C2=NC(C)=NC(N3CCC(CC#N)CC3)=C2C(C)=C1C BPPFPTRSIAYSTC-UHFFFAOYSA-N 0.000 claims 1
- CEIWJMBXBOEKJW-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-diethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CCC1=CC(Br)=CC(CC)=C1N1C2=NC(C)=NC(N3CCC(CC#N)CC3)=C2C(C)=C1 CEIWJMBXBOEKJW-UHFFFAOYSA-N 0.000 claims 1
- SBKIGROTZRCHOY-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-3-yl]ethanol Chemical compound CC1=C(C)C2=C(N3CC(CCO)CCC3)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C SBKIGROTZRCHOY-UHFFFAOYSA-N 0.000 claims 1
- BFMXVFZKPNCHRF-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC#N)CC3)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C BFMXVFZKPNCHRF-UHFFFAOYSA-N 0.000 claims 1
- BYGRMCOTWHGVIX-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]ethanol Chemical compound CC1=C(C)C2=C(N3CCC(CCO)CC3)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C BYGRMCOTWHGVIX-UHFFFAOYSA-N 0.000 claims 1
- BMEIYMQIKFQHND-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]pyrrolidin-3-yl]acetonitrile Chemical compound CC1=C(C)C2=C(N3CC(CC#N)CC3)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C BMEIYMQIKFQHND-UHFFFAOYSA-N 0.000 claims 1
- IDEKLVUWBDUYCK-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=NC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C IDEKLVUWBDUYCK-UHFFFAOYSA-N 0.000 claims 1
- MCOOTAMYJQNJFF-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]ethanol Chemical compound C12=NC(C)=NC(N3CCC(CCO)CC3)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C MCOOTAMYJQNJFF-UHFFFAOYSA-N 0.000 claims 1
- NBJBBEHPAHVHDQ-UHFFFAOYSA-N 2-[1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]propanedinitrile Chemical compound C12=NC(C)=NC(N3CCC(CC3)C(C#N)C#N)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C NBJBBEHPAHVHDQ-UHFFFAOYSA-N 0.000 claims 1
- IOTPQLHPWLTTJV-UHFFFAOYSA-N 2-[1-[7-(4-chloro-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound CC1=C(C)C2=C(N3CCC(CC#N)CC3)N=C(C)N=C2N1C1=C(C)C=C(Cl)C=C1C IOTPQLHPWLTTJV-UHFFFAOYSA-N 0.000 claims 1
- YSHJJVVADPYFAB-UHFFFAOYSA-N 2-[1-[7-(4-chloro-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]acetonitrile Chemical compound C12=NC(C)=NC(N3CCC(CC#N)CC3)=C2C(C)=CN1C1=C(C)C=C(Cl)C=C1C YSHJJVVADPYFAB-UHFFFAOYSA-N 0.000 claims 1
- BSDGMIHPHLTYTK-UHFFFAOYSA-N 2-[1-[7-[2,6-dibromo-4-(trifluoromethyl)phenyl]-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-3-yl]acetonitrile Chemical compound CC1=C(C)C2=C(N3CC(CC#N)CCC3)N=C(C)N=C2N1C1=C(Br)C=C(C(F)(F)F)C=C1Br BSDGMIHPHLTYTK-UHFFFAOYSA-N 0.000 claims 1
- YWXQKYPFAYTTSP-UHFFFAOYSA-N 2-[1-[7-[2,6-dibromo-4-(trifluoromethyl)phenyl]-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-3-yl]ethanol Chemical compound CC1=C(C)C2=C(N3CC(CCO)CCC3)N=C(C)N=C2N1C1=C(Br)C=C(C(F)(F)F)C=C1Br YWXQKYPFAYTTSP-UHFFFAOYSA-N 0.000 claims 1
- VXPOTGOWGMWJLH-UHFFFAOYSA-N 3-[1-[1-(4-bromo-2,6-dichlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound CC1=C(C)C2=C(N3CCC(CCCO)CC3)C=C(C)N=C2N1C1=C(Cl)C=C(Br)C=C1Cl VXPOTGOWGMWJLH-UHFFFAOYSA-N 0.000 claims 1
- SBGUYPIMNLAHJV-UHFFFAOYSA-N 3-[1-[1-(4-bromo-2,6-dichlorophenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound C12=NC(C)=CC(N3CCC(CCCO)CC3)=C2C(C)=CN1C1=C(Cl)C=C(Br)C=C1Cl SBGUYPIMNLAHJV-UHFFFAOYSA-N 0.000 claims 1
- ROWOKQVGKGNFBY-UHFFFAOYSA-N 3-[1-[1-(4-bromo-2,6-dimethylphenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound CC1=C(C)C2=C(N3CCC(CCCO)CC3)C=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C ROWOKQVGKGNFBY-UHFFFAOYSA-N 0.000 claims 1
- BNVDDFDPXVBXCI-UHFFFAOYSA-N 3-[1-[1-(4-chloro-2,6-dimethylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound C12=NC(C)=CC(N3CCC(CCCO)CC3)=C2C(C)=CN1C1=C(C)C=C(Cl)C=C1C BNVDDFDPXVBXCI-UHFFFAOYSA-N 0.000 claims 1
- HOADZJNKZIJGRQ-UHFFFAOYSA-N 3-[1-[2,3,6-trimethyl-1-(2,4,6-trichlorophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound CC1=C(C)C2=C(N3CCC(CCCO)CC3)C=C(C)N=C2N1C1=C(Cl)C=C(Cl)C=C1Cl HOADZJNKZIJGRQ-UHFFFAOYSA-N 0.000 claims 1
- XKIQMKSPWUPKPD-UHFFFAOYSA-N 3-[1-[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound CC1=C(C)C2=C(N3CCC(CCCO)CC3)N=C(C)N=C2N1C1=C(C)C=C(C)C=C1C XKIQMKSPWUPKPD-UHFFFAOYSA-N 0.000 claims 1
- UOXLUYHPSRZJMR-UHFFFAOYSA-N 3-[1-[3,6-dimethyl-1-(2-methylsulfanyl-4-propan-2-ylphenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound CSC1=CC(C(C)C)=CC=C1N1C2=NC(C)=CC(N3CCC(CCCO)CC3)=C2C(C)=C1 UOXLUYHPSRZJMR-UHFFFAOYSA-N 0.000 claims 1
- GTOLYUNLTZAJJN-UHFFFAOYSA-N 3-[1-[7-(4-bromo-2,6-dichlorophenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound CC1=C(C)C2=C(N3CCC(CCCO)CC3)N=C(C)N=C2N1C1=C(Cl)C=C(Br)C=C1Cl GTOLYUNLTZAJJN-UHFFFAOYSA-N 0.000 claims 1
- CVYGPGBFULYIBF-UHFFFAOYSA-N 3-[1-[7-(4-chloro-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]propan-1-ol Chemical compound CC1=C(C)C2=C(N3CCC(CCCO)CC3)N=C(C)N=C2N1C1=C(C)C=C(Cl)C=C1C CVYGPGBFULYIBF-UHFFFAOYSA-N 0.000 claims 1
- LCXFXRNWKCQAFX-UHFFFAOYSA-N 8-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]-8-azabicyclo[3.2.1]octane-3-carbonitrile Chemical compound CC1=C(C)C2=C(N3C4CCC3CC(C4)C#N)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C LCXFXRNWKCQAFX-UHFFFAOYSA-N 0.000 claims 1
- DXISBZGRQMNKTD-UHFFFAOYSA-N [1-[1-(2,4-dibromophenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound C12=NC(C)=CC(N3CCC(CO)CC3)=C2C(C)=CN1C1=CC=C(Br)C=C1Br DXISBZGRQMNKTD-UHFFFAOYSA-N 0.000 claims 1
- VGFSUDRLTBYCSA-UHFFFAOYSA-N [1-[1-(2,4-dichlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)C=C(C)N=C2N1C1=CC=C(Cl)C=C1Cl VGFSUDRLTBYCSA-UHFFFAOYSA-N 0.000 claims 1
- HSXYJQODTSOICO-UHFFFAOYSA-N [1-[1-(2,6-dibromo-4-chlorophenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)C=C(C)N=C2N1C1=C(Br)C=C(Cl)C=C1Br HSXYJQODTSOICO-UHFFFAOYSA-N 0.000 claims 1
- DGNSQMCSKOSKHH-UHFFFAOYSA-N [1-[1-(2,6-dibromo-4-propan-2-ylphenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound BrC1=CC(C(C)C)=CC(Br)=C1N1C2=NC(C)=CC(N3CCC(CO)CC3)=C2C(C)=C1C DGNSQMCSKOSKHH-UHFFFAOYSA-N 0.000 claims 1
- ORZYPLWVVWMVLC-UHFFFAOYSA-N [1-[1-(2-bromo-4-propan-2-ylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound BrC1=CC(C(C)C)=CC=C1N1C2=NC(C)=CC(N3CCC(CO)CC3)=C2C(C)=C1 ORZYPLWVVWMVLC-UHFFFAOYSA-N 0.000 claims 1
- LPSOJDRMKBVCMM-UHFFFAOYSA-N [1-[1-(4-bromo-2,6-dichlorophenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound C12=NC(C)=CC(N3CCC(CO)CC3)=C2C(C)=CN1C1=C(Cl)C=C(Br)C=C1Cl LPSOJDRMKBVCMM-UHFFFAOYSA-N 0.000 claims 1
- OYDLSBGGGHVXRJ-UHFFFAOYSA-N [1-[1-(4-chloro-2,6-dimethylphenyl)-2,3,6-trimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)C=C(C)N=C2N1C1=C(C)C=C(Cl)C=C1C OYDLSBGGGHVXRJ-UHFFFAOYSA-N 0.000 claims 1
- KGDJXDNCNXRLHP-UHFFFAOYSA-N [1-[1-(4-chloro-2,6-dimethylphenyl)-3,6-dimethylpyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound C12=NC(C)=CC(N3CCC(CO)CC3)=C2C(C)=CN1C1=C(C)C=C(Cl)C=C1C KGDJXDNCNXRLHP-UHFFFAOYSA-N 0.000 claims 1
- QZMIOIAZZKLUGZ-UHFFFAOYSA-N [1-[2,3,6-trimethyl-1-(2,4,6-tribromophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)C=C(C)N=C2N1C1=C(Br)C=C(Br)C=C1Br QZMIOIAZZKLUGZ-UHFFFAOYSA-N 0.000 claims 1
- MPNAGMHOOMKBNU-UHFFFAOYSA-N [1-[2,3,6-trimethyl-1-(2,4,6-trichlorophenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)C=C(C)N=C2N1C1=C(Cl)C=C(Cl)C=C1Cl MPNAGMHOOMKBNU-UHFFFAOYSA-N 0.000 claims 1
- APPUHMBXXALEGM-UHFFFAOYSA-N [1-[2,5-dimethyl-7-(2,4,6-tribromophenyl)pyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound C12=NC(C)=NC(N3CCC(CO)CC3)=C2C(C)=CN1C1=C(Br)C=C(Br)C=C1Br APPUHMBXXALEGM-UHFFFAOYSA-N 0.000 claims 1
- WVTKUVAKUUOIBO-UHFFFAOYSA-N [1-[2-methyl-9-(2,4,6-trimethylphenyl)pyrimido[4,5-b]indol-4-yl]piperidin-4-yl]methanol Chemical compound CC1=CC(C)=CC(C)=C1N1C2=NC(C)=NC(N3CCC(CO)CC3)=C2C2=CC=CC=C21 WVTKUVAKUUOIBO-UHFFFAOYSA-N 0.000 claims 1
- HYJMNOWGGUZILR-UHFFFAOYSA-N [1-[3,6-dimethyl-1-(2-methylsulfanyl-4-propan-2-ylphenyl)pyrrolo[2,3-b]pyridin-4-yl]piperidin-4-yl]methanol Chemical compound CSC1=CC(C(C)C)=CC=C1N1C2=NC(C)=CC(N3CCC(CO)CC3)=C2C(C)=C1 HYJMNOWGGUZILR-UHFFFAOYSA-N 0.000 claims 1
- WCRBTMJOMZEUIH-UHFFFAOYSA-N [1-[7-(2,4-dibromophenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound C12=NC(C)=NC(N3CCC(CO)CC3)=C2C(C)=CN1C1=CC=C(Br)C=C1Br WCRBTMJOMZEUIH-UHFFFAOYSA-N 0.000 claims 1
- ZWSZDBDQZZRRCA-UHFFFAOYSA-N [1-[7-(2-bromo-4-propan-2-ylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound BrC1=CC(C(C)C)=CC=C1N1C2=NC(C)=NC(N3CCC(CO)CC3)=C2C(C)=C1 ZWSZDBDQZZRRCA-UHFFFAOYSA-N 0.000 claims 1
- KWVHQRABXCEIPJ-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dichlorophenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)N=C(C)N=C2N1C1=C(Cl)C=C(Br)C=C1Cl KWVHQRABXCEIPJ-UHFFFAOYSA-N 0.000 claims 1
- FPQVQMUAUXZGKB-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-diethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound CCC1=CC(Br)=CC(CC)=C1N1C2=NC(C)=NC(N3CCC(CO)CC3)=C2C(C)=C1 FPQVQMUAUXZGKB-UHFFFAOYSA-N 0.000 claims 1
- OMJNJVWHGBGBLW-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-3-yl]methanol Chemical compound CC1=C(C)C2=C(N3CC(CO)CCC3)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C OMJNJVWHGBGBLW-UHFFFAOYSA-N 0.000 claims 1
- BAAUMRSLVMKPIW-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)N=C(C)N=C2N1C1=C(C)C=C(Br)C=C1C BAAUMRSLVMKPIW-UHFFFAOYSA-N 0.000 claims 1
- GGRHUOGLCCJDDN-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound C12=NC(C)=NC(N3CCC(CO)CC3)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C GGRHUOGLCCJDDN-UHFFFAOYSA-N 0.000 claims 1
- KHYYPSPNVFLJGW-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methyl 3-(diethylamino)propanoate Chemical compound C1CC(COC(=O)CCN(CC)CC)CCN1C1=NC(C)=NC2=C1C(C)=CN2C1=C(C)C=C(Br)C=C1C KHYYPSPNVFLJGW-UHFFFAOYSA-N 0.000 claims 1
- ZUXBYFVIGGJPIF-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methyl decanoate Chemical compound C1CC(COC(=O)CCCCCCCCC)CCN1C1=NC(C)=NC2=C1C(C)=CN2C1=C(C)C=C(Br)C=C1C ZUXBYFVIGGJPIF-UHFFFAOYSA-N 0.000 claims 1
- ZUMSBHWRWMQWOA-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methyl ethyl carbonate Chemical compound C1CC(COC(=O)OCC)CCN1C1=NC(C)=NC2=C1C(C)=CN2C1=C(C)C=C(Br)C=C1C ZUMSBHWRWMQWOA-UHFFFAOYSA-N 0.000 claims 1
- FUUPWNKYRGIBKV-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methyl pyridine-2-carboxylate Chemical compound C12=NC(C)=NC(N3CCC(COC(=O)C=4N=CC=CC=4)CC3)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C FUUPWNKYRGIBKV-UHFFFAOYSA-N 0.000 claims 1
- BTXOVDLASKEDNW-UHFFFAOYSA-N [1-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]pyrrolidin-2-yl]methanol Chemical compound C12=NC(C)=NC(N3C(CCC3)CO)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C BTXOVDLASKEDNW-UHFFFAOYSA-N 0.000 claims 1
- YFSJBGRCSORSKM-UHFFFAOYSA-N [1-[7-(4-chloro-2,6-dimethylphenyl)-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)N=C(C)N=C2N1C1=C(C)C=C(Cl)C=C1C YFSJBGRCSORSKM-UHFFFAOYSA-N 0.000 claims 1
- GVRQVXHJPYHCBO-UHFFFAOYSA-N [1-[7-[2,6-dibromo-4-(trifluoromethyl)phenyl]-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]-3-methylpiperidin-3-yl]methanol Chemical compound CC1=C(C)C2=C(N3CC(C)(CO)CCC3)N=C(C)N=C2N1C1=C(Br)C=C(C(F)(F)F)C=C1Br GVRQVXHJPYHCBO-UHFFFAOYSA-N 0.000 claims 1
- DNUXKPZCFSTBPM-UHFFFAOYSA-N [1-[7-[2,6-dibromo-4-(trifluoromethyl)phenyl]-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]piperidin-4-yl]methanol Chemical compound CC1=C(C)C2=C(N3CCC(CO)CC3)N=C(C)N=C2N1C1=C(Br)C=C(C(F)(F)F)C=C1Br DNUXKPZCFSTBPM-UHFFFAOYSA-N 0.000 claims 1
- OEWHSXMWOOLHIX-UHFFFAOYSA-N [8-[7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethylpyrrolo[2,3-d]pyrimidin-4-yl]-8-azabicyclo[3.2.1]octan-3-yl]methanol Chemical compound C12=NC(C)=NC(N3C4CCC3CC(CO)C4)=C2C(C)=CN1C1=C(C)C=C(Br)C=C1C OEWHSXMWOOLHIX-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- NJAPCAIWQRPQPY-UHFFFAOYSA-N benzyl hydrogen carbonate Chemical compound OC(=O)OCC1=CC=CC=C1 NJAPCAIWQRPQPY-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 13
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 13
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 13
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 206010008118 cerebral infarction Diseases 0.000 description 6
- 208000019901 Anxiety disease Diseases 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 201000006474 Brain Ischemia Diseases 0.000 description 3
- 206010048962 Brain oedema Diseases 0.000 description 3
- 206010008120 Cerebral ischaemia Diseases 0.000 description 3
- 208000030814 Eating disease Diseases 0.000 description 3
- 208000019454 Feeding and Eating disease Diseases 0.000 description 3
- 208000023105 Huntington disease Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000018737 Parkinson disease Diseases 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 208000006752 brain edema Diseases 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 235000014632 disordered eating Nutrition 0.000 description 3
- 206010013663 drug dependence Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000011117 substance-related disease Diseases 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 201000000980 schizophrenia Diseases 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- LLAPDLPYIYKTGQ-UHFFFAOYSA-N 1-aminoethyl Chemical group C[CH]N LLAPDLPYIYKTGQ-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- LDKSCZJUIURGMW-UHFFFAOYSA-N 1-isothiocyanato-3-methylsulfanylpropane Chemical group CSCCCN=C=S LDKSCZJUIURGMW-UHFFFAOYSA-N 0.000 description 1
- 125000001088 1-naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000003287 1H-imidazol-4-ylmethyl group Chemical group [H]N1C([H])=NC(C([H])([H])[*])=C1[H] 0.000 description 1
- 125000000980 1H-indol-3-ylmethyl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[*])C2=C1[H] 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000001216 2-naphthoyl group Chemical group C1=C(C=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000003974 3-carbamimidamidopropyl group Chemical group C(N)(=N)NCCC* 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 101000868045 Homo sapiens Uncharacterized protein C1orf87 Proteins 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102100032994 Uncharacterized protein C1orf87 Human genes 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004859 cyclopropyloxymethyl group Chemical group C1(CC1)OC* 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005935 hexyloxycarbonyl group Chemical group 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002383667 | 2002-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200405982B true ZA200405982B (en) | 2005-09-02 |
Family
ID=32677471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200405982A ZA200405982B (en) | 2002-12-26 | 2004-07-27 | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group. |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20050209253A1 (xx) |
| EP (2) | EP1787992B1 (xx) |
| JP (1) | JP4181126B2 (xx) |
| KR (2) | KR100688395B1 (xx) |
| CN (1) | CN1692115A (xx) |
| AR (1) | AR042667A1 (xx) |
| AT (2) | ATE390426T1 (xx) |
| AU (1) | AU2003292550B8 (xx) |
| BR (1) | BR0307587A (xx) |
| CA (1) | CA2485556C (xx) |
| CL (1) | CL2003002762A1 (xx) |
| DE (2) | DE60319951T2 (xx) |
| EA (1) | EA200401060A1 (xx) |
| ES (2) | ES2325596T3 (xx) |
| HR (1) | HRP20040724A2 (xx) |
| MX (1) | MXPA04008081A (xx) |
| MY (1) | MY141200A (xx) |
| NO (1) | NO20043508L (xx) |
| PL (1) | PL371810A1 (xx) |
| TW (1) | TWI270549B (xx) |
| UA (1) | UA77265C2 (xx) |
| WO (1) | WO2004058767A1 (xx) |
| ZA (1) | ZA200405982B (xx) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4742273B2 (ja) | 2004-01-06 | 2011-08-10 | 大正製薬株式会社 | ピロロピリミジン及びピロロトリアジン誘導体 |
| CA2552598A1 (en) * | 2004-01-06 | 2005-07-21 | Taisho Pharmaceutical Co., Ltd. | Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group |
| RU2006128600A (ru) | 2004-01-06 | 2008-02-20 | Тайсо Фармасьютикал Ко., Лтд. (Jp) | ПРОИЗВОДНЫЕ ТРИАЗАЦИКЛОПЕНТА [cd] ИНДЕНА |
| RU2006135120A (ru) * | 2004-03-05 | 2008-04-10 | Тайсо Фармасьютикал Ко. | Производные пирролопиримидина |
| JP2007161585A (ja) * | 2004-06-25 | 2007-06-28 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
| BRPI0512514A (pt) * | 2004-06-25 | 2008-03-11 | Taisho Pharmaceutical Co Ltd | composto, antagonista para receptores de crf, e, uso de um composto |
| DE102004042607A1 (de) * | 2004-09-03 | 2006-03-09 | Bayer Healthcare Ag | Substituierte Phenylaminothiazole und ihre Verwendung |
| DE102006042143A1 (de) * | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
| DE102006056739A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
| DE102006056740A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| DK2170930T3 (da) | 2007-06-04 | 2012-11-05 | Synergy Pharmaceuticals Inc | Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme |
| DE102007035367A1 (de) * | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
| DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
| DE102007061764A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Anellierte Cyanopyridine und ihre Verwendung |
| DE102007061763A1 (de) | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
| DE102008013587A1 (de) * | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
| AR071717A1 (es) | 2008-05-13 | 2010-07-07 | Array Biopharma Inc | Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer. |
| JP2011520997A (ja) * | 2008-05-29 | 2011-07-21 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | ２−アルコキシ置換ジシアノピリジン類およびそれらの使用 |
| JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
| DE102009006602A1 (de) * | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
| DE102010030688A1 (de) | 2010-06-30 | 2012-01-05 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dicyanopyridine und ihre Verwendung |
| US20120058983A1 (en) | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
| CN103562208B (zh) | 2011-03-15 | 2016-08-31 | 默沙东公司 | 三环促旋酶抑制剂 |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| BR112015019412A8 (pt) | 2013-04-11 | 2019-11-12 | Hoffmann La Roche | inibidores de bace1, seus usos, e composição farmacêutica |
| EP2991988B1 (en) * | 2013-05-02 | 2017-05-31 | F. Hoffmann-La Roche AG | Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists |
| CN114829362A (zh) * | 2019-12-10 | 2022-07-29 | 成都倍特药业股份有限公司 | 一种可用作shp2抑制剂的含氮杂原子的六元并五元芳环衍生物 |
| CN114646700B (zh) * | 2022-03-01 | 2023-10-20 | 浙江国邦药业有限公司 | 一种（s）-吡咯烷-2-甲腈盐酸盐的检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2895961B2 (ja) | 1992-12-17 | 1999-05-31 | フアイザー・インコーポレイテツド | Ｃｒｆアンタゴニストとしてのピロロピリミジン |
| US5646152A (en) | 1994-06-15 | 1997-07-08 | Pfizer Inc. | Methods of administering CRF antagonists |
| CN1056611C (zh) | 1994-06-16 | 2000-09-20 | 美国辉瑞有限公司 | 吡唑并吡啶和吡咯并吡啶,其用途和用于制备它们的中间体 |
| US6187781B1 (en) | 1997-03-26 | 2001-02-13 | Taisho Pharmaceutical Co., Ltd. | 4-Tetrahydropyridylpyrimidine derivatives |
| WO2000053604A1 (fr) | 1999-03-11 | 2000-09-14 | Taisho Pharmaceutical Co., Ltd. | Derives de carbamoyl tetrahydropyridine |
| AR028782A1 (es) | 2000-07-05 | 2003-05-21 | Taisho Pharmaceutical Co Ltd | Derivados heterociclicos tetrahidropiridino o piperidino |
| RU2006128600A (ru) * | 2004-01-06 | 2008-02-20 | Тайсо Фармасьютикал Ко., Лтд. (Jp) | ПРОИЗВОДНЫЕ ТРИАЗАЦИКЛОПЕНТА [cd] ИНДЕНА |
-
2003
- 2003-12-23 AR ARP030104818A patent/AR042667A1/es unknown
- 2003-12-23 TW TW092136594A patent/TWI270549B/zh not_active IP Right Cessation
- 2003-12-24 ES ES06019987T patent/ES2325596T3/es not_active Expired - Lifetime
- 2003-12-24 AT AT03768186T patent/ATE390426T1/de not_active IP Right Cessation
- 2003-12-24 US US10/504,981 patent/US20050209253A1/en not_active Abandoned
- 2003-12-24 EP EP06019987A patent/EP1787992B1/en not_active Expired - Lifetime
- 2003-12-24 AT AT06019987T patent/ATE430151T1/de not_active IP Right Cessation
- 2003-12-24 PL PL03371810A patent/PL371810A1/xx not_active Application Discontinuation
- 2003-12-24 MY MYPI20034990A patent/MY141200A/en unknown
- 2003-12-24 CA CA002485556A patent/CA2485556C/en not_active Expired - Fee Related
- 2003-12-24 JP JP2004562918A patent/JP4181126B2/ja not_active Expired - Fee Related
- 2003-12-24 DE DE60319951T patent/DE60319951T2/de not_active Expired - Lifetime
- 2003-12-24 BR BR0307587-7A patent/BR0307587A/pt not_active IP Right Cessation
- 2003-12-24 EA EA200401060A patent/EA200401060A1/ru unknown
- 2003-12-24 CN CNA2003801004264A patent/CN1692115A/zh active Pending
- 2003-12-24 ES ES03768186T patent/ES2302949T3/es not_active Expired - Lifetime
- 2003-12-24 UA UA20040907464A patent/UA77265C2/uk unknown
- 2003-12-24 EP EP03768186A patent/EP1467997B8/en not_active Expired - Lifetime
- 2003-12-24 AU AU2003292550A patent/AU2003292550B8/en not_active Ceased
- 2003-12-24 KR KR1020047013348A patent/KR100688395B1/ko not_active IP Right Cessation
- 2003-12-24 DE DE60327477T patent/DE60327477D1/de not_active Expired - Lifetime
- 2003-12-24 MX MXPA04008081A patent/MXPA04008081A/es active IP Right Grant
- 2003-12-24 WO PCT/JP2003/016598 patent/WO2004058767A1/en active IP Right Grant
- 2003-12-24 KR KR1020067025000A patent/KR100808756B1/ko not_active IP Right Cessation
- 2003-12-26 CL CL200302762A patent/CL2003002762A1/es unknown
-
2004
- 2004-07-27 ZA ZA200405982A patent/ZA200405982B/en unknown
- 2004-08-10 HR HR20040724A patent/HRP20040724A2/hr not_active Application Discontinuation
- 2004-08-23 NO NO20043508A patent/NO20043508L/no not_active Application Discontinuation
-
2008
- 2008-04-21 US US12/106,873 patent/US7932259B2/en not_active Expired - Fee Related
-
2010
- 2010-11-22 US US12/951,556 patent/US8455511B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200405982B (en) | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group. | |
| AU2019231551B2 (en) | Substituted 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones | |
| AU2005257496B2 (en) | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists | |
| JP6460991B2 (ja) | 抗菌剤として使用するための三環式ジャイレース阻害剤 | |
| KR101478368B1 (ko) | 유기 화합물 | |
| ZA200610043B (en) | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists | |
| JP2004537557A5 (xx) | ||
| RU2012102424A (ru) | СЕЛЕКТИВНЫЕ ИНГИБИТОРЫ Haspin КИНАЗЫ | |
| EP1701961A1 (en) | Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group | |
| EP0915093B1 (en) | Amide derivatives | |
| WO2005066142A2 (en) | Pyrrolopyrimidine and pyrrolotriazine derivatives as crf receptor antagonists | |
| JP2006036762A (ja) | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 | |
| EP3623369A1 (en) | Novel morpholinyl amine compounds for the treatment of autoimmune disease | |
| EP1442040B1 (en) | Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists | |
| JP2007169216A (ja) | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |